Tandem Diabetes (TNDM) Tops Q4 EPS by 22c, Revenues Beat; Offers FY19 Revenue Guidance Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St rises on AI gains as oil slides, Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips briefly below $100 on Saudi exports, hopes of US-Iran diplomacy
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- AMD stock jumps as chip rally builds ahead of summit
Tandem Diabetes Care (TNDM) PT Raised to $60 at Cowen Following 'Blowout'
February 27, 2019 8:31 AM ESTCowen analyst Doug Schenkel raised the price target on Tandem Diabetes Care (NASDAQ: TNDM) to $60.00 (from $40.00) while maintaining a Outperform rating.
The analyst commented, "TNDM posted blowout top to bottom Q4 results. 2019 guidance was also materially ahead of consensus, and still... More
Tandem Diabetes Care (TNDM) PT Raised to $67 at Piper Jaffray
February 27, 2019 3:03 AM ESTPiper Jaffray analyst JP McKim raised the price target on Tandem Diabetes Care (NASDAQ: TNDM) to $67.00 (from $60.00) while maintaining a Overweight rating.
... MoreTandem Diabetes (TNDM) Confirms Succession Plan for CEO and Board
February 26, 2019 4:52 PM ESTTandem Diabetes Care®, Inc. (NASDAQ: TNDM) today announced a succession plan for its chief executive officer (CEO) and select members of its board of directors.
CEO Succession Plan
After nearly 12 years of service as Tandems President and CEO, Kim D. Blickenstaff will transition to a newly-created position of Executive Chairman of the Board of Directors. John F. Sheridan will succeed Mr. Blickenstaff, assuming the role of President and CEO effective March 1, 2019. Mr. Sheridan has served as the Companys Executive Vice President and Chief Operating Officer since April 2013.
John... More
